During the COVID-19 pandemic, “Marijuana smokers had better outcomes and mortality compared to non-users”, according to a new study.
Researchers introduced the study this week at The American College of Chest Physicians’ (CHEST) annual conference, and it was published in the October issue of the Chest Journal.
“Marijuana use is becoming increasingly prevalent worldwide, yet the full spectrum of its effects largely remains unknown”, states the study’s “purpose” section. “Although cannabinoids have immunomodulatory properties, there remains a significant gap in our understanding of the potential impact of marijuana use on COVID-19 outcomes.”
Continue reading